Shedding of gangliosides by human medulloblastoma cells.
Shedding of immunosuppressive gangliosides is an important characteristic of both experimental and human tumors. Using a medulloblastoma cell line, Daoy, with a very high ganglioside expression (141 +/- 13 nmol/10(8) cells) and a well-characterized ganglioside complement, we have now studied ganglioside shedding by human brain tumor cells. Shedding of gangliosides, quantified by metabolic radiolabeling, was significant (169 pmol/10(8) cells/h) and was generalized with respect to the major ganglioside carbohydrate structures (G(M2), G(M3), and G(D1a)). For each ganglioside, however, shedding was selective for ceramide structures containing shorter fatty acyl chains. Rapid and ceramide-selective shedding was confirmed in two additional human medulloblastoma cell lines, D341 Med and D283 Med (112 and 59 pmol/10(8) cells/h). Significant ganglioside shedding is therefore a common characteristic of human medulloblastoma cells and may influence the biological behavior of this tumor, in view of immunosuppressive and other biological properties of shed gangliosides.
Chang
F
F
Children's Research Institute, and Department of Pediatrics, The George Washington University School of Medicine, Washington, DC 20010, USA.
Li
R
R
Ladisch
S
S
D002455:Cell Division; D002518:Ceramides / Q000032:analysis; D002528:Cerebellar Neoplasms / Q000378:metabolism*; D005227:Fatty Acids / Q000032:analysis; D005732:Gangliosides / Q000737:chemistry / Q000378:metabolism*; D005910:Glioma / Q000378:metabolism; D006801:Humans; D008527:Medulloblastoma / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D002518:Ceramides; D005227:Fatty Acids; D005732:Gangliosides